U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06901297) titled 'The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients' on March 24.
Brief Summary: Multicenter double-blind placebo-controlled randomized in parallel groups clinical trial of the efficacy and safety of Raphamin in the treatment of acute rhinosinusitis in adult patients.
Study Start Date: March 25
Study Type: INTERVENTIONAL
Condition:
Rhinosinusitis
Rhinosinusitis Acute
Intervention:
DRUG: Raphamin
Oral administration
DRUG: Placebo
Oral administration
Recruitment Status: RECRUITING
Sponsor: Materia Medica Holding
Published by HT Digital Content Services with permission from Health...